You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股生物科技股全线高开 康希诺(6185.HK)涨6%
格隆汇 05-19 09:25
格隆汇5月19日丨隔夜因疫苗取得进展美股全线大涨,今早港股生物科技股继续全线上涨。其中,康希诺生物高开6%,锦欣生殖、信达生物、迈博药业高开超3%,康方生物、歌礼制药、药明康德和中国抗体高开超2%,康宁杰瑞制药高开1.5%。有消息称,高瓴正进行高瓴5期美元基金的募集,目标规模高达130亿美元(折合人民币约923亿元)。相关人士表示,上述募集资金中,100亿美元将投入到并购领域,30亿美元将分配给成长型投资和风险投资。而且,将主要瞄准疫情之下出现的新机会,尤其是中国市场的机会。接近高瓴的市场人士称,生物医药和医疗器械领域一直是高瓴的重点投资方向,预期未来高瓴还会继续布局。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account